US 12091388
Solid state forms of Reproxalap
granted A61PA61P27/02
Quick answer
US patent 12091388 (Solid state forms of Reproxalap) held by TEVA PHARMACEUTICALS INTERNATIONAL GMBH expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICALS INTERNATIONAL GMBH
- Grant date
- Tue Sep 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P27/02